Arum Therapeutics
3 known investors
Find your way into Arum Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
900 people can intro you to Mark
Ask Richard Heyman to introduce you to Mark Taegon Baik
You →Richard · together at Exelixis →Mark
Sign up to find every way you can get introduced to Arum Therapeutics
- Your email: who you already know at Arum Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Arum Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Arum Therapeutics is a drug development company focused on identifying and targeting novel biological targets and signaling pathways to create new therapeutics.
Founders & leadership
MT

Mark Taegon BaikFounderMark Taegon Baik is founder of Arum Therapeutics and has over 20 years of experience in drug discovery and development across cancer, inflammation, and metabolism. He has worked in pharmaceutical companies in Korea and the US, with expertise in project strategy, licensing, and business development partnerships.
Investors · 3
Frequently asked questions
- What does Arum Therapeutics do?
- Arum Therapeutics is a drug development company focused on identifying and targeting novel biological targets and signaling pathways to create new therapeutics.
- Who founded Arum Therapeutics?
- Arum Therapeutics was founded by Mark Taegon Baik.
- Who are Arum Therapeutics's investors?
- Arum Therapeutics's investors include Aju IB Investment, DAYLI Partners, SBI Investment Korea Co. Ltd..
